News | May 27, 2022
Torrent Pharma acquires four brands from Dr Reddy’s
The integration and transition of the brands are expected to be completed by June 2022.
The integration and transition of the brands are expected to be completed by June 2022.
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
Objective tracking data combined with cohort data to drive medicine of the future
Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
Subscribe To Our Newsletter & Stay Updated
